DYME

DY001 · Aqumen Biopharmaceuticals, N.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DYME, covering 2009-03-02 to 2009-03-02. Get the full timeline:

Most recent: Clinical Trial Update: DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery [Phase 3]

See pricing